Pub Date : 2023-11-16DOI: 10.17352/2455-3786.000036
AJ Ehi-Imuse, AA Adeyekun, Pfi Irabor, CO Azubike, SO Izevbekhai
Background: The management of HIV infection is often challenging as it can affect every organ in the body including the kidneys. Determination of the Resistivity Indices (RI) of the intra-renal arteries is an emerging non-invasive tool that could predict renal disease. Aims & objectives: To determine the renal volume, parenchymal pattern, as well as the RI of the intra-renal arteries by Doppler ultrasonography in adult HIV/AIDS patients and correlate findings with CD4 count, viral load and serum creatinine. Materials & methods: This is a comparative cross-sectional descriptive study that involved sonographic assessment of the renal dimensions, parenchymal echogenicity, and Doppler velocimetry of the segmental intra-renal arteries in 100 apparently healthy confirmed HIV-seronegative control subjects and an equal number of confirmed HIV-seropositive adult patients at Retroviral (RV) clinic of our hospital. A Doppler ultrasound machine with a 3.5MHz Curvilinear probe was used. Data analysis: Data obtained was analyzed and presented as means which were compared using Student’s t - test, and p values < 0.05 at 95% intervals were considered significant. Pearson’s correlation coefficient was used to assess correlation. Results: The renal volumes were larger in the HIV/AIDS subjects (right: 125.94 ± 34.02 cm3 and left: 138.99 ± 33.29cm3) than in controls (p = < 0.01) with the left also larger than the right in both HIV/AIDS and control subjects (p = < 0.01, < 0.01) respectively. There were significantly more individuals with abnormal renal echogenicity in the HIV/AIDS subjects than in the controls. The RI was significantly greater in the HIV/AIDS than in control subjects. Both renal volumes showed a weak negative correlation with CD4, viral load, and serum creatinine which was not statistically significant. There was a statistically significant weak negative correlation between renal echogenicity and CD4 but a positive correlation with viral load and serum creatinine. RI showed weak negative correlations with serum creatinine and weak positive correlations with CD4 count. Conclusion: There is a significant difference in renal volume, echogenicity, and RI in HIV/AIDS patients compared to the controls. Renal echogenicity is a better predictor of serum creatinine levels than renal volume and RI. Thus, renal volume and RI do not provide sufficient correlation to be used as a means of monitoring HIV/AIDS patients with renal impairment.
背景:艾滋病病毒感染会影响包括肾脏在内的身体各个器官,因此,对艾滋病病毒感染者的管理往往具有挑战性。测定肾内动脉的电阻率指数(RI)是一种新兴的非侵入性工具,可以预测肾脏疾病。目的和目标:通过多普勒超声波检查确定成年艾滋病毒/艾滋病患者的肾脏体积、实质形态以及肾内动脉的电阻率指数,并将结果与 CD4 细胞计数、病毒载量和血清肌酐相关联。材料与方法:这是一项横断面描述性比较研究,对本院逆转录病毒(RV)门诊 100 名表面健康的确诊 HIV 阴性对照受试者和相同数量的确诊 HIV 阳性成年患者的肾脏尺寸、实质回声和肾内动脉节段多普勒速度进行超声评估。使用多普勒超声仪和 3.5MHz Curvilinear 探头。数据分析:对获得的数据进行分析,并以均值表示,采用学生 t 检验进行比较,P 值小于 0.05(95% 间隔)视为显著。皮尔逊相关系数用于评估相关性。结果艾滋病毒/艾滋病受试者的肾体积(右:125.94 ± 34.02 立方厘米,左:138.99 ± 33.29 立方厘米)大于对照组(P = < 0.01),艾滋病毒/艾滋病受试者和对照组受试者的左肾体积也分别大于右肾体积(P = < 0.01,< 0.01)。在艾滋病毒/艾滋病受试者中,肾脏回声异常者明显多于对照组。艾滋病患者的 RI 明显高于对照组。两种肾脏体积均与 CD4、病毒载量和血清肌酐呈弱负相关,但无统计学意义。肾脏回声与 CD4 呈弱负相关,但与病毒载量和血清肌酐呈正相关,统计学意义重大。RI与血清肌酐呈弱负相关,与CD4计数呈弱正相关。结论与对照组相比,HIV/AIDS 患者的肾脏体积、回声和 RI 存在明显差异。肾脏回声比肾脏体积和 RI 更能预测血清肌酐水平。因此,肾脏体积和 RI 并不能提供足够的相关性来作为监测肾功能受损的艾滋病毒/艾滋病患者的手段。
{"title":"Sonographic appearances of the kidneys and correlation with CD4 count and viral load in adult HIV/AIDS patients in a rural-based infectious disease hospital in sub-saharan Africa","authors":"AJ Ehi-Imuse, AA Adeyekun, Pfi Irabor, CO Azubike, SO Izevbekhai","doi":"10.17352/2455-3786.000036","DOIUrl":"https://doi.org/10.17352/2455-3786.000036","url":null,"abstract":"Background: The management of HIV infection is often challenging as it can affect every organ in the body including the kidneys. Determination of the Resistivity Indices (RI) of the intra-renal arteries is an emerging non-invasive tool that could predict renal disease. Aims & objectives: To determine the renal volume, parenchymal pattern, as well as the RI of the intra-renal arteries by Doppler ultrasonography in adult HIV/AIDS patients and correlate findings with CD4 count, viral load and serum creatinine. Materials & methods: This is a comparative cross-sectional descriptive study that involved sonographic assessment of the renal dimensions, parenchymal echogenicity, and Doppler velocimetry of the segmental intra-renal arteries in 100 apparently healthy confirmed HIV-seronegative control subjects and an equal number of confirmed HIV-seropositive adult patients at Retroviral (RV) clinic of our hospital. A Doppler ultrasound machine with a 3.5MHz Curvilinear probe was used. Data analysis: Data obtained was analyzed and presented as means which were compared using Student’s t - test, and p values < 0.05 at 95% intervals were considered significant. Pearson’s correlation coefficient was used to assess correlation. Results: The renal volumes were larger in the HIV/AIDS subjects (right: 125.94 ± 34.02 cm3 and left: 138.99 ± 33.29cm3) than in controls (p = < 0.01) with the left also larger than the right in both HIV/AIDS and control subjects (p = < 0.01, < 0.01) respectively. There were significantly more individuals with abnormal renal echogenicity in the HIV/AIDS subjects than in the controls. The RI was significantly greater in the HIV/AIDS than in control subjects. Both renal volumes showed a weak negative correlation with CD4, viral load, and serum creatinine which was not statistically significant. There was a statistically significant weak negative correlation between renal echogenicity and CD4 but a positive correlation with viral load and serum creatinine. RI showed weak negative correlations with serum creatinine and weak positive correlations with CD4 count. Conclusion: There is a significant difference in renal volume, echogenicity, and RI in HIV/AIDS patients compared to the controls. Renal echogenicity is a better predictor of serum creatinine levels than renal volume and RI. Thus, renal volume and RI do not provide sufficient correlation to be used as a means of monitoring HIV/AIDS patients with renal impairment.","PeriodicalId":142637,"journal":{"name":"Journal of HIV for Clinical and Scientific Research","volume":"36 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139269134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-16DOI: 10.17352/2455-3786.000035
T. Odinga, O. Azuonwu, H. Opusunju Boma, Godwin Porobe Popnen Tee, C. U. Gabriel-Brisibe, N. Ihua, Brantley Akuru Udiomine, M. Akram
Background: The use of Antiretroviral Therapy (ART) has greatly improved the health and lifespan of people living with HIV, however, hepatic dysfunction has been associated with HIV. This study investigated the liver function biomarkers of women living with HIV and who are on ART. Methods: A cross-sectional study was conducted on HIV-positive pregnant women and HIV-positive non-pregnant women in Rivers State, Nigeria. A total of 330 women between 15-60 years participated in this study. HIV-negative pregnant and non-pregnant women served as a control to the test subjects. Sociodemographic data were collected using a well-structured questionnaire. Blood samples were collected for biochemical assay of the liver function biomarkers. The subjects were on Tenofovir-Lamivudine-Efavirenz (TLE) antiretroviral therapy. Data were analyzed statistically on IBM SPSS Version 25 using student’s t - test, ANOVA and compared using the Post hoc test. Results: The results obtained showed a significant increase at p ≤ 0.05 in the ALP, ALT and AST levels of both HIV-positive pregnant and non-pregnant women when compared to the control group. The serum TP level of HIV-positive pregnant women decreased in comparison to the control group. However, the decrease was not statistically significant at p ≤ 0.05. A statistically significant increase in the total protein level was observed in the HIV-positive non-pregnant women when compared to the control group. The albumin level in HIV-positive pregnant women had a statistically insignificant increase in comparison to the control group. HIV-positive non-pregnant women had a decreased level of Albumin at p ≤ 0.05 in comparison to the control group. Conclusion: The findings of the study suggest that the HIV-positive pregnant and non-pregnant women on ART are prone to adverse alterations in their liver function biomarkers in comparison to the control groups, hence they are vulnerable to liver dysfunction. Thus proper care and regular investigations should be carried out on HIV-positive women on ART.
背景:抗逆转录病毒治疗(ART)的使用极大地改善了艾滋病毒感染者的健康和寿命,然而,肝功能障碍与艾滋病毒有关。这项研究调查了接受抗逆转录病毒治疗的艾滋病毒感染者的肝功能生物标志物。方法:对尼日利亚河流州艾滋病毒阳性孕妇和艾滋病毒阳性非孕妇进行横断面研究。共有330名年龄在15-60岁之间的女性参与了这项研究。hiv阴性的孕妇和非孕妇作为测试对象的对照。使用结构良好的问卷收集社会人口统计数据。采集血样进行肝功能生物标志物生化检测。受试者接受替诺福韦-拉米夫定-依非韦伦(TLE)抗逆转录病毒治疗。采用IBM SPSS Version 25对数据进行统计分析,采用学生t检验、方差分析,采用事后检验进行比较。结果:与对照组相比,hiv阳性孕妇和非孕妇的ALP、ALT和AST水平均显著升高,p≤0.05。与对照组相比,hiv阳性孕妇血清TP水平下降。但p≤0.05,差异无统计学意义。与对照组相比,在hiv阳性的非孕妇中观察到总蛋白水平有统计学意义上的显著增加。与对照组相比,hiv阳性孕妇的白蛋白水平有统计学上不显著的增加。与对照组相比,hiv阳性非孕妇白蛋白水平降低(p≤0.05)。结论:本研究结果提示,与对照组相比,接受抗逆转录病毒治疗的hiv阳性孕妇和非孕妇的肝功能生物标志物容易发生不良改变,因此容易发生肝功能障碍。因此,应对接受抗逆转录病毒治疗的艾滋病毒阳性妇女进行适当的护理和定期调查。
{"title":"Assessment on liver function biomarkers in HIV positive pregnant and Non-pregnant women on Antiretroviral therapy in Rivers State, Nigeria","authors":"T. Odinga, O. Azuonwu, H. Opusunju Boma, Godwin Porobe Popnen Tee, C. U. Gabriel-Brisibe, N. Ihua, Brantley Akuru Udiomine, M. Akram","doi":"10.17352/2455-3786.000035","DOIUrl":"https://doi.org/10.17352/2455-3786.000035","url":null,"abstract":"Background: The use of Antiretroviral Therapy (ART) has greatly improved the health and lifespan of people living with HIV, however, hepatic dysfunction has been associated with HIV. This study investigated the liver function biomarkers of women living with HIV and who are on ART. Methods: A cross-sectional study was conducted on HIV-positive pregnant women and HIV-positive non-pregnant women in Rivers State, Nigeria. A total of 330 women between 15-60 years participated in this study. HIV-negative pregnant and non-pregnant women served as a control to the test subjects. Sociodemographic data were collected using a well-structured questionnaire. Blood samples were collected for biochemical assay of the liver function biomarkers. The subjects were on Tenofovir-Lamivudine-Efavirenz (TLE) antiretroviral therapy. Data were analyzed statistically on IBM SPSS Version 25 using student’s t - test, ANOVA and compared using the Post hoc test. Results: The results obtained showed a significant increase at p ≤ 0.05 in the ALP, ALT and AST levels of both HIV-positive pregnant and non-pregnant women when compared to the control group. The serum TP level of HIV-positive pregnant women decreased in comparison to the control group. However, the decrease was not statistically significant at p ≤ 0.05. A statistically significant increase in the total protein level was observed in the HIV-positive non-pregnant women when compared to the control group. The albumin level in HIV-positive pregnant women had a statistically insignificant increase in comparison to the control group. HIV-positive non-pregnant women had a decreased level of Albumin at p ≤ 0.05 in comparison to the control group. Conclusion: The findings of the study suggest that the HIV-positive pregnant and non-pregnant women on ART are prone to adverse alterations in their liver function biomarkers in comparison to the control groups, hence they are vulnerable to liver dysfunction. Thus proper care and regular investigations should be carried out on HIV-positive women on ART.","PeriodicalId":142637,"journal":{"name":"Journal of HIV for Clinical and Scientific Research","volume":"70 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125990433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-29DOI: 10.17352/2455-3786.000034
Onyedinachi Okezie, A. Raphael, Jimbo Grace, Essien Esther, Eyo Andy, Badejo Rebecca, O. Ngozi, Odutuga George, Oke Olufemi
Nigeria ranks third among countries with the highest burden of Human Immuno-Deficiency Virus (HIV) infection in the world. The 2019 Nigeria National HIV/AIDS Indicator and Impact Survey showed that 1.9 million people were living with HIV and AIDS in Nigeria as of 2018 [1].
{"title":"Prevalence and pattern of psychological disorders among key populations living with HIV/AIDS: findings from ECEWS supported global fund IMPACT project OSS centers in Southern Nigeria","authors":"Onyedinachi Okezie, A. Raphael, Jimbo Grace, Essien Esther, Eyo Andy, Badejo Rebecca, O. Ngozi, Odutuga George, Oke Olufemi","doi":"10.17352/2455-3786.000034","DOIUrl":"https://doi.org/10.17352/2455-3786.000034","url":null,"abstract":"Nigeria ranks third among countries with the highest burden of Human Immuno-Deficiency Virus (HIV) infection in the world. The 2019 Nigeria National HIV/AIDS Indicator and Impact Survey showed that 1.9 million people were living with HIV and AIDS in Nigeria as of 2018 [1].","PeriodicalId":142637,"journal":{"name":"Journal of HIV for Clinical and Scientific Research","volume":"76 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130465921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-02DOI: 10.17352/2455-3786.000033
Carlea Annunziata, Mazzarelli Laura Letizia, Sarno Laura, Fulgione Caterina, Mantelli Dalila, G. Maurizio
The risk of mother-to-infant transmission of HIV 1 during breastfeeding ranges from 10% to 15% in the absence of maternal Antiretroviral Therapy (ART) and infant Antiretroviral (ARV) prophylaxis. WHO guidelines 2016 recommend women living with HIV and fully supported for ART adherence should breastfeed for at least 12 months and up to 24 months or longer. Anyway, in high-income settings, women living with HIV are suggested to avoid breastfeeding, regardless of maternal viral load or antiretroviral therapy status. The advantages of breastfeeding in low and middle-income settings are well recognized. This brief narrative review aims to summarize existing evidence on mechanisms and risk factors for HIV transmission during breastfeeding and the possible prevention strategies in the context of ART adherence.
{"title":"Breastfeeding and women living with HIV: Is it possible to move beyond the avoidance?","authors":"Carlea Annunziata, Mazzarelli Laura Letizia, Sarno Laura, Fulgione Caterina, Mantelli Dalila, G. Maurizio","doi":"10.17352/2455-3786.000033","DOIUrl":"https://doi.org/10.17352/2455-3786.000033","url":null,"abstract":"The risk of mother-to-infant transmission of HIV 1 during breastfeeding ranges from 10% to 15% in the absence of maternal Antiretroviral Therapy (ART) and infant Antiretroviral (ARV) prophylaxis. WHO guidelines 2016 recommend women living with HIV and fully supported for ART adherence should breastfeed for at least 12 months and up to 24 months or longer. Anyway, in high-income settings, women living with HIV are suggested to avoid breastfeeding, regardless of maternal viral load or antiretroviral therapy status. The advantages of breastfeeding in low and middle-income settings are well recognized. This brief narrative review aims to summarize existing evidence on mechanisms and risk factors for HIV transmission during breastfeeding and the possible prevention strategies in the context of ART adherence.","PeriodicalId":142637,"journal":{"name":"Journal of HIV for Clinical and Scientific Research","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125564647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-24DOI: 10.17352/2455-3786.000032
M. David Sáez, R. Nadia Valdés, M. Cristian Fernández, E. Rocío Pacheco
Progressive multifocal leukoencephalopathy is a pathology associated with the presence of the JC virus, although it occurs in other conditions, nowadays most cases occur in patients with AIDS, in severe stages of immunosuppression. This condition, and hence its name, has always been associated with the presence of intracerebral lesions, where it can have a wide distribution. However, it is very rare, if ever, to report lesions of this disease in the spinal cord. We present a case of a 40-year-old patient, an HIV carrier in the AIDS stage, who, in addition to presenting brain lesions, had multiple lesions at the cervical spinal cord level. We believe that these lesions may be more common than believed and should be intentionally sought if possible.
{"title":"Progressive multifocal leukoencephalopathy, more than an encephalopathy","authors":"M. David Sáez, R. Nadia Valdés, M. Cristian Fernández, E. Rocío Pacheco","doi":"10.17352/2455-3786.000032","DOIUrl":"https://doi.org/10.17352/2455-3786.000032","url":null,"abstract":"Progressive multifocal leukoencephalopathy is a pathology associated with the presence of the JC virus, although it occurs in other conditions, nowadays most cases occur in patients with AIDS, in severe stages of immunosuppression. This condition, and hence its name, has always been associated with the presence of intracerebral lesions, where it can have a wide distribution. However, it is very rare, if ever, to report lesions of this disease in the spinal cord. We present a case of a 40-year-old patient, an HIV carrier in the AIDS stage, who, in addition to presenting brain lesions, had multiple lesions at the cervical spinal cord level. We believe that these lesions may be more common than believed and should be intentionally sought if possible.","PeriodicalId":142637,"journal":{"name":"Journal of HIV for Clinical and Scientific Research","volume":"82 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122021652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}